2019 Annual Meeting | C16 - Cerebrovascular Disease I: Prevention

Date Saturday 05/04/19

Time 09:30 AM - 11:30 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry B. Goldstein, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants should be able to discuss recent changes in stroke epidemiology, recommend appropriate lifestyle changes for stroke prevention, understand stroke prevention issues specific to women, and discuss risks and benefits of resumption of anticoagulation after brain hemorrhage.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Neurohospitalist, Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
09:30 AM - 09:55 AM EDT	Speaker	Changing Epidemiology and Importance of Lifestyle Larry B. Goldstein, MD, FAHA, FAAN
09:55 AM - 10:10 AM EDT	Q&A	Questions and Discussion Larry B. Goldstein, MD, FAHA, FAAN
10:10 AM - 10:35 AM EDT	Speaker	Stroke Risk and Prevention Unique to Women Cheryl Bushnell, MD, MHS
10:35 AM - 10:45 AM EDT	Q&A	Questions and Discussion Cheryl Bushnell, MD, MHS
10:45 AM - 11:10 AM EDT	Speaker	Resuming Anticoagulation after Brain Hemorrhage Steven M. Greenberg, MD, PhD, FAAN
11:10 AM - 11:20 AM EDT	Q&A	Questions and Discussion Steven M. Greenberg, MD, PhD, FAAN
11:20 AM - 11:30 AM EDT	Closing Remarks	Closing Remarks

Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Cheryl Bushnell, MD, MHS	Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Steven M. Greenberg, MD, PhD, FAAN	Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��